Estonia: manufacture of pharmaceutical products production value 2020

The production value of the basic pharmaceutical products and pharmaceutical preparations manufacturing industry in Estonia increased by 13.9 million euros (+32.25 percent) since the previous year. Therefore, the production value in Estonia reached a peak in 2020 with 57 million euros.
The production value is defined as turnover, plus or minus the changes in stocks of finished products, work in progress and goods and services purchased for resale, minus the purchases of goods and services for resale, plus capitalized production, plus other operating income (excluding subsidies). Income and expenditure classified as financial or extra-ordinary in company accounts is excluded from production value.

Find more statistics on the basic pharmaceutical products and pharmaceutical preparations manufacturing industry in Estonia with key insights such as turnover and personnel costs.

Production value of the manufacture of basic pharmaceutical products and pharmaceutical preparations in Estonia from 2011 to 2020 (in million euros)

Characteristic	Annual production value in million euros
2020	57
2019	43.1
2018b	36.8
2017	38.2
2016	50.7
2015	43.9
2014	39.8
2013	42
2012	41.2
2011	40.4

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

March 2023

More information

Region

Estonia

Survey time period

2011 to 2020

Supplementary notes

b: Break in time series.
Data for the year 2016 was not provided by the source.
The source adds the following information: Production value measures the amount actually produced by the unit, based on sales, including changes in stocks and the resale of goods and services. The production value is defined as turnover, plus or minus the changes in stocks of finished products, work in progress and goods and services purchased for resale, minus the purchases of goods and services for resale, plus capitalised production, plus other operating income (excluding subsidies). Income and expenditure classified as financial or extra-ordinary in company accounts is excluded from production value.
Data coverage corresponds to code C21 of NACE Rev2.

Citation formats